COOKSON PEIRCE & CO INC

Position in NVS — Novartis AG

CIK 1141455 PITTSBURGH, PA

Position in NVS

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$44,483,404

+$1,160,908 QoQ

Shares Held

283,840

+0.1% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

1.53%

of 13F equity value

Holder Rank

#64

of 1,603 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

COOKSON PEIRCE & CO INC holds $68,000,592 across 6 Drug Manufacturers - General names. NVS ranks #1 (65.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG This page	283,840	$44,483,404
2	LLY	ELI LILLY & Co	16,449	$19,729,425
3	AZN	Astrazeneca PLC	9,055	$1,717,009
4	GILD	Gilead Sciences, Inc.	8,977	$1,134,154
5	BMY	Bristol Myers Squibb Co	9,943	$572,915
6	JNJ	Johnson & Johnson	1,432	$363,685

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$44,483,404	283,840	+0.1%	Shares	Sole	2026-07-23
2026-03-31	$43,322,496	283,617	+5.5%	Shares	Sole	2026-04-30
2025-12-31	$37,079,171	268,943	-1.2%	Shares	Sole	2026-02-11
2025-09-30	$34,902,952	272,169	+1.7%	Shares	Sole	2025-11-06
2025-06-30	$32,374,410	267,535	+20.4%	Shares	Sole	2025-07-30
2025-03-31	$24,762,717	222,127	+3048.1%	Shares	Sole	2025-05-13
2024-09-30	$811,581	7,056	+0.1%	Shares	Sole	2024-11-12
2024-06-30	$750,223	7,047	-2.4%	Shares	Sole	2024-08-14
2024-03-31	$698,390	7,220	-0.6%	Shares	Sole	2024-04-23
2023-12-31	$733,244	7,262	+1.8%	Shares	Sole	2024-01-30
2023-09-30	$726,771	7,135	-95.9%	Shares	Sole	2023-11-07
2022-06-30	$14,849,723	175,674	+2500.3%	Shares	Sole	2022-07-20
2020-06-30	$590,069	6,756	-2.8%	Shares	Sole	2020-08-07
2020-03-31	$573,274	6,953	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.